It is possible to substantially enhance these antibodies’ therapeutic potential via humanization, effectively reducing ...

Although the media and the public are worried about the infectious risks of transfusion, hemovigilance reports show that antigen-antibody reactions are responsible for the vast majority of acute ...

Favourable safety profile for world’s first LAG-3 agonist, IMP761, with no treatment related adverse events to dateAdditional safety data and ...

A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has ...

For life science startups, the road to innovation often begins with accurate and reliable diagnostic tools. Whether it’s identifying diseases or contributing to groundbreaking research, diagnostic ...

A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions.

Virax Biolabs Group Limited (NASDAQ:VRAX – Get Free Report) was the recipient of a large drop in short interest in the month ...

A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed, as reported ...

Instil Bio is a clinical-stage biotech focusing on personalized immunotherapy. Check out my recommendation for TIL stock.

SAN DIEGO — Single-agent epcoritamab demonstrated deep and durable responses in chimeric antigen receptor T (CAR ... that epcoritamab — a bispecific antibody therapy available off the shelf ...

Bispecific antibodies have been big news for several years at the ... This study evaluated the efficacy of elranatamab ...

Food allergies, involving the immune system, are often confused with food intolerances, stemming from digestive issues. While ...